|
Status |
Public on Jun 24, 2012 |
Title |
A10 P2_AG1478 BMP2.7 A |
Sample type |
RNA |
|
|
Source name |
primary human keratinocytes treated with AG1478+BMP2/7
|
Organism |
Homo sapiens |
Characteristics |
cell: primary human keratinocytes
|
Treatment protocol |
vehicle (0.2% DMSO), the EGFR inhibitor AG1478 (10 uM), recombinant human BMP2/7 heterodimer (200 ng/ml) or a combination of AG1478+BMP2/7 (10 uM and 200 ng/ml, respectively) for 48 hours.
|
Growth protocol |
Primary human keratinocytes (line Lka, passage 2) were cultured in Keratinocyte Serum Free Medium.
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was extracted using the QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. A DNase I digestion was included. Quality control was performed with Agilent Bioanalyser.
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
|
|
|
Hybridization protocol |
Standard Illumina hybridization protocol
|
Scan protocol |
Standard Illumina scanning protocol
|
Description |
4285752030_E AG1478+BMP2/7 treated replicate 1
|
Data processing |
The bead-level data were preprocessed using BASH (Cairns et al. (2008) Bioinformatics 24(24):2921-2), a function from the beadarray package (Dunning et al (2007) Bioinformatics 23(16):2183-4) in Bioconductor, and also log base 2 transformed and quantile normalised using GeneSpring GX software.
|
|
|
Submission date |
Dec 19, 2011 |
Last update date |
Sep 14, 2015 |
Contact name |
Chandra Chilamakuri |
E-mail(s) |
[email protected]
|
Organization name |
Cancer Research UK Cambridge Institute
|
Street address |
Robinson Way
|
City |
Cambridge |
ZIP/Postal code |
CB2 0RE |
Country |
United Kingdom |
|
|
Platform ID |
GPL6884 |
Series (2) |
GSE34557 |
Diverse epigenetic strategies interact to control epidermal differentiation [Illumina bead array] |
GSE34558 |
Diverse epigenetic strategies interact to control epidermal differentiation |
|